Global Longlife Hospital and Research Limited (BOM:543520)
India · Delayed Price · Currency is INR 20.90
-1.10 (-5.00%)
At close: Jan 22, 2026
BOM:543520 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2019 - 2020 |
Operating Revenue | - | 5.77 | 135.15 | 235.02 | 328.15 | 327.03 | Upgrade |
Other Revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.21 | - | Upgrade |
| 0.03 | 5.8 | 135.18 | 235.05 | 328.36 | 327.03 | Upgrade | |
Revenue Growth (YoY) | -99.85% | -95.71% | -42.49% | -28.42% | 0.41% | -2.51% | Upgrade |
Cost of Revenue | 15.84 | 34.25 | 118.74 | 172.21 | 214.77 | 249.89 | Upgrade |
Gross Profit | -15.81 | -28.45 | 16.45 | 62.84 | 113.59 | 77.14 | Upgrade |
Selling, General & Admin | 0.42 | 0.42 | 0.13 | 0.28 | 0.75 | - | Upgrade |
Other Operating Expenses | -7.07 | 12.5 | 18.74 | 21.85 | 29.65 | 22.75 | Upgrade |
Operating Expenses | -6.67 | 17.74 | 31.36 | 33.8 | 41.84 | 35.81 | Upgrade |
Operating Income | -9.15 | -46.19 | -14.92 | 29.05 | 71.75 | 41.32 | Upgrade |
Interest Expense | -0.17 | -2.92 | -7.04 | -3.2 | -15.08 | -22.81 | Upgrade |
Interest & Investment Income | 1.3 | 1.3 | 0.59 | 1.26 | 2.04 | 0.6 | Upgrade |
Other Non Operating Income (Expenses) | -56.88 | -0.03 | -0.71 | -0.03 | -1 | -1.53 | Upgrade |
EBT Excluding Unusual Items | -64.89 | -47.84 | -22.08 | 27.08 | 57.71 | 17.58 | Upgrade |
Gain (Loss) on Sale of Investments | 5.71 | 5.71 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 43.12 | 43.12 | -0.58 | - | -0.61 | - | Upgrade |
Pretax Income | -16.06 | 0.99 | -22.66 | 27.08 | 57.1 | 17.58 | Upgrade |
Income Tax Expense | 7.58 | -1 | -0.78 | 8.8 | 21.36 | -2.89 | Upgrade |
Net Income | -23.63 | 1.99 | -21.88 | 18.28 | 35.74 | 20.47 | Upgrade |
Net Income to Common | -23.63 | 1.99 | -21.88 | 18.28 | 35.74 | 20.47 | Upgrade |
Net Income Growth | - | - | - | -48.86% | 74.59% | - | Upgrade |
Shares Outstanding (Basic) | 11 | 11 | 11 | 10 | 7 | 7 | Upgrade |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 10 | 7 | 7 | Upgrade |
Shares Change (YoY) | 0.07% | - | 3.11% | 45.48% | - | - | Upgrade |
EPS (Basic) | -2.25 | 0.19 | -2.08 | 1.79 | 5.11 | 2.92 | Upgrade |
EPS (Diluted) | -2.25 | 0.19 | -2.08 | 1.79 | 5.11 | 2.92 | Upgrade |
EPS Growth | - | - | - | -64.94% | 74.85% | - | Upgrade |
Free Cash Flow | -43.77 | 122.48 | -61.21 | -424.2 | 89.49 | 68.34 | Upgrade |
Free Cash Flow Per Share | -4.17 | 11.66 | -5.83 | -41.66 | 12.79 | 9.76 | Upgrade |
Gross Margin | - | - | 12.17% | 26.74% | 34.59% | 23.59% | Upgrade |
Operating Margin | -33870.37% | -796.35% | -11.03% | 12.36% | 21.85% | 12.64% | Upgrade |
Profit Margin | -87529.63% | 34.26% | -16.19% | 7.78% | 10.88% | 6.26% | Upgrade |
Free Cash Flow Margin | -162114.82% | 2111.78% | -45.28% | -180.47% | 27.25% | 20.90% | Upgrade |
EBITDA | -6.77 | -41.38 | -2.43 | 40.71 | 83.19 | 54.37 | Upgrade |
EBITDA Margin | - | - | -1.80% | 17.32% | 25.33% | 16.63% | Upgrade |
D&A For EBITDA | 2.37 | 4.81 | 12.49 | 11.67 | 11.43 | 13.05 | Upgrade |
EBIT | -9.15 | -46.19 | -14.92 | 29.05 | 71.75 | 41.32 | Upgrade |
EBIT Margin | - | - | -11.03% | 12.36% | 21.85% | 12.64% | Upgrade |
Effective Tax Rate | - | - | - | 32.51% | 37.41% | - | Upgrade |
Revenue as Reported | - | 55.93 | 135.78 | 237.4 | 330.43 | 327.66 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.